📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses. (2019)

First Author: Abd Hamid M

Attributed to: MRC and DfID contribution to jointly funded rapid response strategic award funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2326-6066.cir-18-0885

PubMed Identifier: 31213473

Publication URI: http://europepmc.org/abstract/MED/31213473

Type: Journal Article/Review

Volume: 7

Parent Publication: Cancer immunology research

Issue: 8

ISSN: 2326-6066